Next, by sequencing and in silico drug screen of fmn2 knockdown, small-molecule metaxalone has been discovered to be a regulator of microtubule dynamics and a novel therapeutic drug for the treatment of peripheral nerve injury (Au et al., 2023). The gene discussed is FMN2; the disease is peripheral nerve injury.